Neighborhood walkability and risk of gestational diabetes.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
02 2020
Historique:
received: 26 09 2019
revised: 10 12 2019
accepted: 25 12 2019
entrez: 23 2 2020
pubmed: 23 2 2020
medline: 8 1 2021
Statut: ppublish

Résumé

Higher neighborhood walkability has been associated with a lower risk of type 2 diabetes mellitus (T2DM) by promoting greater physical activity (thereby reducing weight and lowering insulin resistance). However, it is not known if walkability may similarly reduce maternal risk of gestational diabetes mellitus (GDM), which arises in the setting of the severe physiologic insulin resistance of pregnancy. Indeed, the insulin resistance of pregnancy is primarily driven by placental hormones and not maternal weight gain. Thus, we sought to evaluate the impact of neighborhood walkability on maternal risk of GDM and the pathophysiologic determinants thereof (insulin sensitivity and pancreatic beta-cell function). In this study, 1318 women reported their pregravid physical activity (Baecke questionnaire) while undergoing an oral glucose tolerance test (OGTT) at mean 29.3 weeks' gestation. The OGTT identified 290 women with GDM and enabled assessment of insulin sensitivity and beta-cell function. Based on their residential Walk Score, the women were stratified into the following four established categories of neighborhood walkability: car dependent (n=328), somewhat walkable (n=315), very walkable (n=406), and walker's paradise (n=269). There was a progressive increase in pregravid total physical activity (p=0.002), non-sport leisure-time activity (p=0.009) and sport activity (p=0.01) across the walkability groups (from car dependent to somewhat walkable to very walkable to walker's paradise), coupled with a concomitant decline in pre-pregnancy body mass index (p=0.007). However, in pregnancy, the groups did not differ in gestational weight gain (p=0.80). Moreover, the walkability groups also did not differ in mean adjusted insulin sensitivity, beta-cell function, or glycemia on the antepartum OGTT. On logistic regression analysis, Walk Score did not predict GDM (OR=1.001, 95% CI 0.995 to 1.007). Neighborhood walkability is not a significant determinant of maternal risk of GDM. Thus, in contrast to T2DM, the effect of neighborhood design on incidence of GDM will be comparatively modest.

Identifiants

pubmed: 32086280
pii: 8/1/e000938
doi: 10.1136/bmjdrc-2019-000938
pmc: PMC7039598
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : MOP-84206
Pays : Canada
Organisme : CIHR
ID : PJT-156286
Pays : Canada

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open. 2017 Apr 8;7(4):e013889
pubmed: 28391234
JAMA. 2016 May 24-31;315(20):2211-20
pubmed: 27218630
BMC Public Health. 2017 Dec 19;17(1):960
pubmed: 29258476
N Engl J Med. 2008 Jul 3;359(1):61-73
pubmed: 18596274
BMJ. 2014 Feb 10;348:g1285
pubmed: 24513442
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Diabetes. 1979 Dec;28(12):1039-57
pubmed: 510803
JAMA Intern Med. 2015 Aug;175(8):1311-20
pubmed: 26121402
Am J Clin Nutr. 1982 Nov;36(5):936-42
pubmed: 7137077
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
JAMA Pediatr. 2018 Feb 1;172(2):136-142
pubmed: 29279903
Diabetes Care. 2015 May;38(5):844-51
pubmed: 25693837
J Clin Endocrinol Metab. 2017 Mar 1;102(3):903-913
pubmed: 27935767
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Nat Rev Endocrinol. 2012 Nov;8(11):639-49
pubmed: 22751341
Med Sci Sports Exerc. 1997 Jun;29(6 Suppl):S1-205
pubmed: 9243481
Br J Sports Med. 2011 Nov;45(14):1144-8
pubmed: 20418525
Obesity (Silver Spring). 2008 Aug;16(8):1901-7
pubmed: 18551118
Diabetologia. 2006 Feb;49(2):289-97
pubmed: 16391903
Health Rep. 2015 Jul;26(7):3-10
pubmed: 26177041
Lancet Diabetes Endocrinol. 2015 Oct;3(10):767-77
pubmed: 26165396
Diabetes Care. 1998 Aug;21 Suppl 2:B19-26
pubmed: 9704223
Diabet Med. 2009 Dec;26(12):1198-203
pubmed: 20002470
Obesity (Silver Spring). 2018 Sep;26(9):1396-1404
pubmed: 30230252
Diabetes Care. 2013 Feb;36(2):302-8
pubmed: 22988302
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Diabetes Care. 1997 Apr;20(4):537-44
pubmed: 9096977
Am J Prev Med. 2010 Nov;39(5):460-3
pubmed: 20965384
Int J Environ Res Public Health. 2011 Nov;8(11):4160-79
pubmed: 22163200
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Diabetes Care. 2011 Dec;34(12):2502-7
pubmed: 21972411
Am J Prev Med. 2013 Aug;45(2):158-66
pubmed: 23867022
Circulation. 2012 Feb 7;125(5):729-37
pubmed: 22311885

Auteurs

Simone Kew (S)

Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.

Chang Ye (C)

Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.

Sadia Mehmood (S)

Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.

Anthony J Hanley (AJ)

Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.
Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada.

Mathew Sermer (M)

Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, Ontario, Canada.

Bernard Zinman (B)

Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.
Division of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada.
Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.

Ravi Retnakaran (R)

Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada Ravi.Retnakaran@sinaihealthsystem.ca.
Division of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada.
Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH